SCHEMBL14033378

SCHEMBL14033378

Oc1ccc(C(O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 2/20 0.52
CYP3A4 P08684 1/20 0.52
CYP19A1 P11511 1/20 0.52
CYP11B1 P15538 1/20 0.52
CYP11B2 P19099 1/20 0.52
MAPK1 P28482 3/20 0.48
ESR1 P03372 5/20 0.44
ESR2 Q92731 5/20 0.44
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
TSHR P16473 3/20 0.43
HIF1A Q16665 3/20 0.43
TAAR1 Q96RJ0 2/20 0.43
HTR3A P46098 1/20 0.43
NFKB1 P19838 1/20 0.43
BRD4 O60885 1/20 0.43
TDP1 Q9NUW8 3/20 0.42
KDM4E B2RXH2 1/20 0.41
ALOX15 P16050 1/20 0.41
APEX1 P27695 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1426754 0.89 TSHR (0.50) CYP19A1MAPK1TSHRHIF1ABRD4
Diphenylmethanol SCHEMBL11366184 0.89 MEN1 (0.45) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
Bis(4-Hydroxyphenyl)Methanol SCHEMBL3642317 0.87 CYP3A4 (0.62) CYP17A1CYP3A4CYP19A1CYP11B1CYP11B2
SCHEMBL36217 0.82 CYP19A1 (0.56) CYP3A4CYP19A1MAPK1ESR1ESR2
Parachlorophenol SCHEMBL28864 0.81
Parachlorophenol SCHEMBL7730292 0.81 MAPK1 (0.65) CYP3A4MAPK1ESR1ESR2HIF1A
Parachlorophenol SCHEMBL6119005 0.81 MAPK1 (0.65) CYP3A4MAPK1ESR1ESR2HIF1A
Parachlorophenol SCHEMBL30086664 0.81
SCHEMBL477349 0.80 IDO1 (0.54) TSHRHPGD
SCHEMBL477552 0.80 IDO1 (0.54) TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116444445-A Quinazolinone compound and preparation method thereof 河北科技大学 2023-07-18 CN disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed